Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants

A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved to be effective and without potentially allergic lung reactions.

https://t.co/MRFwrCXIlQ https://t.co/Su3nMs4CNW